Clinical Trial Update: Phase III Study to Evaluate the Efficacy and Safety of HOB-048 CR Tab. in Comparison With HOB-048 Syrup in Patients With Cough Due to Acute or Chronic Bronchitis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating efficacy and safety of HOB-048 CR tablets versus HOB-048 syrup for cough associated with acute or chronic bronchitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Cough

Drugs mentioned

• HOB-048 CR Tab. (Levotuss CR)
• HOB-048 Syrup (Levotuss)

Snippet

Sponsor: Hyundai Pharm | Conditions: Evaluate the Efficacy and Safety of Levotuss CR Tab. in Comparison With Levotuss Syrup in Patients With Cough Due to Acute or Chronic Bronchitis | Phase 3 | Status: COMPLETED